有指征时使用抗生素的经会阴前列腺穿刺活检的癌症检出率与并发症
这项观察性队列研究评估了1288例在门诊局麻下接受经会阴超声引导系统穿刺活检(TPB-US)的患者,对前列腺影像报告和数据系统3-5级病灶加做MRI认知融合靶向穿刺,仅对尿路感染风险增高者给予抗生素预防。活检初治患者总体前列腺癌检出率为73%,临床显著前列腺癌(csPCa)检出率为63%;TPB-US住院发生率为1%(13/1288),低于经直肠超声引导活检的4%(8/214)和经直肠MRI引导活检的3%(7/219)(P=0.002)。
要点
- TPB-US在门诊局麻下操作简便,活检初治患者csPCa检出率达63%。
- TPB-US住院发生率为1%(13/1288),低于经直肠途径的4%和3%。
- 抗生素预防仅用于尿路感染风险增高的患者。
核心结论
- 当代系统联合靶向TPB-US结合MRI认知融合在门诊环境下易于操作,csPCa检出率高且操作相关并发症发生率低。
研究设计与样本
- 观察性队列研究,纳入在一所大型教学医院接受TPB-US前列腺活检的男性,共评估1288例TPB-US操作。
主要发现
- 活检初治患者总体前列腺癌检出率为73%,csPCa(ISUP分级≥2)检出率为63%。
- TPB-US住院发生率为1%(13/1288),TRB-US为4%(8/214),TRB-MRI为3%(7/219)(P=0.002)。
关键数值与推荐
- csPCa定义为ISUP分级≥2。
- 仅对尿路感染风险增高的患者给予抗生素预防。
- 对前列腺影像报告和数据系统3-5级病灶采用MRI认知融合靶向穿刺。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the prostate cancer (PCa) detection rate, including clinically significant prostate cancer (csPCa), in a large cohort of patients who underwent transperineal ultrasonography-guided systematic prostate biopsy (TPB-US) using a probe-mounted transperineal access system, with magnetic resonance imaging (MRI) cognitive fusion in case of a Prostate Imaging-Reporting and Data System grade 3-5 lesion, under local anaesthesia in an outpatient setting. Additionally, to compare the incidence of procedure-related complications with a cohort of patients undergoing transrectal ultrasonography-guided (TRB-US) and transrectal MRI-guided biopsies (TRB-MRI). PATIENTS AND METHODS: This was an observational cohort study in men who underwent TPB-US prostate biopsy in a large teaching hospital. For each participant, prostate-specific antigen level, clinical tumour stage, prostate volume, MRI parameters, number of (targeted) prostate biopsies, biopsy International Society of Uropathology (ISUP) grade and procedure-related complications were assessed. csPCa was defined as ISUP grade ≥2. Antibiotic prophylaxis was only given in those with an increased risk of urinary tract infection. RESULTS: A total of 1288 TPB-US procedures were evaluated. The overall detection rate for PCa in biopsy-naive patients was 73%, and for csPCa it was 63%. The incidence of hospitalization was 1% in TPB-US (13/1288), compared to 4% in TRB-US (8/214) and 3% in TRB-MRI (7/219; P = 0.002). CONCLUSIONS: Contemporary combined systematic and target TPB-US with MRI cognitive fusion is easy to perform in an outpatient setting, with a high detection rate of csPCa and a low incidence of procedure-related complications.
引用
- Boevé LMS, Bloemendal FT, de Bie KCC, et al. Cancer detection and complications of transperineal prostate biopsy with antibiotics when indicated. BJU Int. 2023. PMID: 37155185. doi:10.1111/bju.16041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。